$PBYI
PUMA BIOTECHNOLOGY, INC.

2015 Q2 Form 10-Q Financial Statement

#000156459015006819 Filed on August 10, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $1.800M $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.530M $3.900M
YoY Change 41.79% 71.81%
% of Gross Profit
Research & Development $59.38M $35.00M
YoY Change 69.65% 235.26%
% of Gross Profit
Depreciation & Amortization $190.0K $150.0K
YoY Change 26.67% 50.0%
% of Gross Profit
Operating Expenses $64.91M $38.91M
YoY Change 66.85% 206.17%
Operating Profit -$64.91M -$38.91M
YoY Change 66.85% 206.17%
Interest Expense $210.0K $70.00K
YoY Change 200.0% -30.0%
% of Operating Profit
Other Income/Expense, Net $10.00K $61.00K
YoY Change -83.61% 7.02%
Pretax Income -$64.69M -$38.84M
YoY Change 66.56% 207.04%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$64.69M -$38.84M
YoY Change 66.55% 207.07%
Net Earnings / Revenue -3594.11%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.012M -$1.290M
COMMON SHARES
Basic Shares Outstanding 32.15M 30.12M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $282.4M $178.4M
YoY Change 58.3% 65.95%
Cash & Equivalents $59.84M $55.40M
Short-Term Investments $222.5M $123.0M
Other Short-Term Assets $5.400M $3.500M
YoY Change 54.29% 218.18%
Inventory
Prepaid Expenses
Receivables $0.00 $1.800M
Other Receivables $0.00 $1.760M
Total Short-Term Assets $287.8M $183.6M
YoY Change 56.75% 48.74%
LONG-TERM ASSETS
Property, Plant & Equipment $2.600M $1.900M
YoY Change 36.84% 15.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.00M $10.50M
YoY Change 14.29% 262.07%
Total Long-Term Assets $14.56M $12.50M
YoY Change 16.49% 174.91%
TOTAL ASSETS
Total Short-Term Assets $287.8M $183.6M
Total Long-Term Assets $14.56M $12.50M
Total Assets $302.4M $196.1M
YoY Change 54.19% 53.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.44M $18.80M
YoY Change -44.45% 146.59%
Accrued Expenses $15.66M $9.100M
YoY Change 72.03% -25.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.10M $27.90M
YoY Change -6.46% 40.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.500M $1.100M
YoY Change 36.36% 0.0%
Total Long-Term Liabilities $1.500M $1.100M
YoY Change 36.36% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.10M $27.90M
Total Long-Term Liabilities $1.500M $1.100M
Total Liabilities $27.58M $29.00M
YoY Change -4.89% 38.37%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $673.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $274.8M $167.0M
YoY Change
Total Liabilities & Shareholders Equity $302.4M $196.1M
YoY Change 54.22% 53.21%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$64.69M -$38.84M
YoY Change 66.55% 207.07%
Depreciation, Depletion And Amortization $190.0K $150.0K
YoY Change 26.67% 50.0%
Cash From Operating Activities -$34.55M -$17.37M
YoY Change 98.91% 57.91%
INVESTING ACTIVITIES
Capital Expenditures -$360.0K -$320.0K
YoY Change 12.5% 77.78%
Acquisitions
YoY Change
Other Investing Activities -$67.76M -$90.33M
YoY Change -24.99% 361.1%
Cash From Investing Activities -$68.12M -$90.65M
YoY Change -24.85% 358.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.040M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -34.55M -17.37M
Cash From Investing Activities -68.12M -90.65M
Cash From Financing Activities 7.040M 0.000
Net Change In Cash -95.63M -108.0M
YoY Change -11.47% 882.0%
FREE CASH FLOW
Cash From Operating Activities -$34.55M -$17.37M
Capital Expenditures -$360.0K -$320.0K
Free Cash Flow -$34.19M -$17.05M
YoY Change 100.53% 57.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Investment Income Interest
InvestmentIncomeInterest
336000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-38905000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-38844000
CY2015Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1484000
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
213000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26099000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-117148000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10444000
us-gaap Net Income Loss
NetIncomeLoss
-117148000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
364000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-64694000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
64913000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15655000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
673505000
CY2015Q2 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
185000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-64913000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38915000
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1215000
CY2015Q2 us-gaap Liabilities
Liabilities
27583000
CY2015Q2 us-gaap Assets
Assets
302361000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
279000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-64786000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-86000
CY2015Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
190.00
us-gaap Depreciation And Amortization
DepreciationAndAmortization
369000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-179000
us-gaap Share Based Compensation
ShareBasedCompensation
48297000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1760000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-8053000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-100000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
5096000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4553000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8105000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13789000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
556000
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
-215000
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
9000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-84570000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-34420000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
791000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
426000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-82708000
us-gaap Share Based Compensation
ShareBasedCompensation
12330000
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
66000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
86000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.29
us-gaap Net Income Loss
NetIncomeLoss
-58638000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-80000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38844000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58718000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
48297000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1215000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.96
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29843966
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.68
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31874346
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30117819
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-58638000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21534000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
205133000
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.01
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3978126
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
785411
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
161577
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
509924
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2614856
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M12D
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-92000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-117234000
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32158108
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-71000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4273000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1694000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
176726000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
179000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
110000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
186720000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
125520000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
66891000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
43348000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-120799000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18942
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
102.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2041
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4089995
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1475139
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
89.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
200.95
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
197.51
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
40.69
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
97.49
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
126.52
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
112.75
CY2015Q2 pbyi Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
160.58
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
81.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
44.21
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
28.23
pbyi Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y6M
pbyi Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm
P9Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
431635000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
78671000
CY2015Q2 pbyi Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIntrinsicValue
48086000
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
128640000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
115.49
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2591565
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
600543
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
161577
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
115.44
CY2015Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
62200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2015Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
16199000
CY2015Q2 pbyi Accrued Development Costs
AccruedDevelopmentCosts
9697000
CY2015Q2 pbyi Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
2197000
CY2015Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
273000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3127000
CY2015Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
147000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28194000
CY2015Q2 pbyi Share Based Compensation Effect On Earnings Per Share Basic And Diluted
ShareBasedCompensationEffectOnEarningsPerShareBasicAndDiluted
0.88
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
300000

Files In Submission

Name View Source Status
0001564590-15-006819-index-headers.html Edgar Link pending
0001564590-15-006819-index.html Edgar Link pending
0001564590-15-006819.txt Edgar Link pending
0001564590-15-006819-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201508072227074211178.jpg Edgar Link pending
g201508072227076241179.jpg Edgar Link pending
pbyi-10q_20150630.htm Edgar Link pending
pbyi-20150630.xml Edgar Link completed
pbyi-20150630.xsd Edgar Link pending
pbyi-20150630_cal.xml Edgar Link unprocessable
pbyi-20150630_def.xml Edgar Link unprocessable
pbyi-20150630_lab.xml Edgar Link unprocessable
pbyi-20150630_pre.xml Edgar Link unprocessable
pbyi-ex101_82.htm Edgar Link pending
pbyi-ex102_132.htm Edgar Link pending
pbyi-ex311_8.htm Edgar Link pending
pbyi-ex312_6.htm Edgar Link pending
pbyi-ex321_7.htm Edgar Link pending
pbyi-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending